drugset / Trial / NCT01064024
Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
Phase 3
Completed
233 enrolled
Amneal Pharmaceuticals, LLC
Biostudy Solutions, LLC · collabOxford Pharmaceutical Resources, Inc. · collabSristek Clinical Research Solutions Limited · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety and efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as a short term analgesic treatment for the primary symptoms of pain or burning when passing urine associated with uncomplicated urinary tract infections (uUTI)
Timeline
- Start
- 2009-12
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Phenazopyridine | Small molecule | 200 mg | — |